2-[4-[2-[[(2S)-2-hydroxy-3-(1H-indol-4-yloxy)propyl]amino]-2-methylpropyl]phenoxy]pyridine-3-carboxamide | 340781-98-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-[4-[2-[[(2S)-2-hydroxy-3-(1H-indol-4-yloxy)propyl]amino]-2-methylpropyl]phenoxy]pyridine-3-carboxamide
• CAS: 340781-98-8
• 化学式: C₂₇H₃₀N₄O₄
• 分子量: 474.56
• InChiKey: CACWGOZTEAWZKE-IBGZPJMESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  35
• 可旋转键数：
  11
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  123
• 氢给体数：
  4
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-[4-[2-[[(2S)-2-hydroxy-3-(1H-indol-4-yloxy)propyl]amino]-2-methylpropyl]phenoxy]pyridine-3-carboxamide 在 对羟基苯甲酸 作用下， 以 乙醇 、 乙酸乙酯 为溶剂， 以82%的产率得到
  参考文献：
  名称：

  Aryloxy propanolamines for improving livestock production

  摘要：

  本申请揭示了一种由结构式(I)表示的化合物：R1是取代或未取代的芳基；R2和R3独立地为-H、C1-C4直链或支链烷基；R4和R5独立地为-H、C1-C4直链或支链烷基，或者与其键合的氮原子一起形成非芳香杂环环。环A和环B独立地进一步取代为零、一个或两个取代基。还包括上述结构式的生理上可接受的盐。本申请还揭示了一种促进家畜动物生长、饲料利用效率和/或瘦体重生产的方法。该方法包括向动物投与所述结构式所示的一个或多个化合物或其生理上可接受的盐的有效量。

  公开号：

  US06841563B1
• 作为产物：
  描述：

  (S)-2-[4-[2-[2-hydroxy-3-(1H-indol-4-yloxy)propylamino]-2-methylpropyl]-phenoxy]-3-pyridinecarbonitrile hydrochloride salt 在 sodium hydroxide 、 双氧水 作用下， 以 水 、 二甲基亚砜 为溶剂， 反应 2.33h， 以86%的产率得到2-[4-[2-[[(2S)-2-hydroxy-3-(1H-indol-4-yloxy)propyl]amino]-2-methylpropyl]phenoxy]pyridine-3-carboxamide
  参考文献：
  名称：

  Aryloxy propanolamines for improving livestock production

  摘要：

  本申请揭示了一种由结构式(I)表示的化合物：R1是取代或未取代的芳基；R2和R3独立地为-H、C1-C4直链或支链烷基；R4和R5独立地为-H、C1-C4直链或支链烷基，或者与其键合的氮原子一起形成非芳香杂环环。环A和环B独立地进一步取代为零、一个或两个取代基。还包括上述结构式的生理上可接受的盐。本申请还揭示了一种促进家畜动物生长、饲料利用效率和/或瘦体重生产的方法。该方法包括向动物投与所述结构式所示的一个或多个化合物或其生理上可接受的盐的有效量。

  公开号：

  US06841563B1

文献信息

• US6841563B1
  申请人：——

  公开号：US6841563B1

  公开（公告）日：2005-01-11
• [EN] PROCESS FOR THE PREPARATION OF ARYLOXY PROPANOLAMINES<br/>[FR] PROCEDE DE PREPARATION D'ARYLOXYPROPANOLAMINES
  申请人：LILLY CO ELI

  公开号：WO2001036412A1

  公开（公告）日：2001-05-25

  Disclosed is a method of preparing and purifying an aryloxy propanolamine ester represented by structural formula (I): R1 is an aryl group or a substituted aryl group. R2 is a C1 to C6 straight or branched chain alkyl group or a C7 to C9 substituted or unsubstituted aralkyl group. The method comprises the step of reacting an epoxide starting material with an amine starting material to form the aryloxy propanolamine ester, which can then be reacted with an acid to form an ammonium salt, and crystallizing said ammonium salt. The epoxide starting material and amine starting material are represented by structural formulas, respectively (II) and (III). Purified aryloxy propanolamine esters can be converted to aryloxy propanolamine amides, which are useful as drugs for the treatment of obesity and Type II diabetes, and as feed additives for livestock to produce leaner meat.
• [EN] TREATING WASTING SYNDROMES WITH ARYLOXY PROPANOLAMINES<br/>[FR] TRAITEMENT DES SYNDROMES CACHECTIQUES AU MOYEN DE PROPANOLAMINES ARYLOXY
  申请人：LILLY CO ELI

  公开号：WO2001035947A2

  公开（公告）日：2001-05-25

  Disclosed is a method of treating a subject with a Wasting Syndrome. The method comprising the step of administering to the subject an effective amount of a compound represented by Structural Formula (I), Ar is a substituted or unsubstituted aryl group. Ar is preferably a monocyclic heteroaryl group or a fused polycyclic heteroaryl group. Ring A has zero, one or more additional substituents. R1 and R2 are independently -H or a C1-C4 alkyl group. W is -CH2-, -CH2CH2- or -CH2CH2CH2-. R3 is a substituted or unsubstituted phenyl or pyridyl group.
• Aryloxy propanolamines for improving livestock production
  申请人：Hopkins Randall Bruce

  公开号：US06841563B1

  公开（公告）日：2005-01-11

  Disclosed is a compound represented by structural formula (I): R1 is a substituted or unsubstituted aryl group. R2 and R3 are independently —H, a C1-C4 straight chained or branched alkyl group. R4 and R5 are independently —H, a C1-C4 straight chained or branched alkyl group or, taken together with the nitrogen atom to which each is bonded, a non-aromatic heterocyclic ring. Ring A and Ring B are independently further substituted with zero, one or two substituents. Physiologically acceptable salts of structural formula shown above are also included. Also disclosed is a method promoting growth, efficiency of feed utilization and/or production of lean body mass in a livestock animal. The method comprises administering to the animal an effective amount of one or more compounds represented by the structural formula as shown or a physiologically acceptable salt thereof.

  本申请揭示了一种由结构式(I)表示的化合物：R1是取代或未取代的芳基；R2和R3独立地为-H、C1-C4直链或支链烷基；R4和R5独立地为-H、C1-C4直链或支链烷基，或者与其键合的氮原子一起形成非芳香杂环环。环A和环B独立地进一步取代为零、一个或两个取代基。还包括上述结构式的生理上可接受的盐。本申请还揭示了一种促进家畜动物生长、饲料利用效率和/或瘦体重生产的方法。该方法包括向动物投与所述结构式所示的一个或多个化合物或其生理上可接受的盐的有效量。